Current and emerging second-generation triptans in acute migraine therapy: a comparative review.
about
Migraine in the era of precision medicineHow does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials.Recurrent headaches may be caused by cerebral toxoplasmosisEletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan.Renal infarction during the use of rizatriptan and zolmitriptan: two case reports.Therapies in development for the treatment of migraine.Reassessing the contraindication of zolmitriptan and serotonin reuptake inhibitors: an evidence-based pharmacotherapeutic case report.Triptans and chest symptoms: the role of pulmonary vasoconstriction.Cis-urocanic acid, a sunlight-induced immunosuppressive factor, activates immune suppression via the 5-HT2A receptor.Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms.Triptans in pregnancy.A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraine.Tripstar: a comprehensive patient-based approach to compare triptans.Vascular effects of the new anti-migraine agent almotriptan on human cranial and peripheral arteries.Almotriptan increases pain-free status in patients with acute migraine treated in placebo-controlled clinical trials.5HT1B/1D agonists.Formulation and Evaluation of Almotriptan Malate Nasal Drops.The 5-HT1D/1B receptor agonist sumatriptan enhances fear of simulated speaking and reduces plasma levels of prolactin.Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies.Thermoreversible nanoethosomal gel for the intranasal delivery of Eletriptan hydrobromide.Application of a Reliable LC-MS/MS Method for Determination of Rizatriptan in Healthy Subject Samples: Demonstration of Assay Reproducibility by Incurred Sample Reanalysis
P2860
Q26748947-0705624E-55F3-43AF-99F0-94412E18E019Q30692301-52C52DCF-C78D-47A3-97D3-491E3AD59017Q34171704-D6D35243-2696-4FE7-8B76-5228EFF4DE14Q34205990-4A15A1D6-4DCD-4B5B-B1D6-7D32C99FF5F4Q34566527-0B25E6C6-A192-40D4-94DB-BD85BAB9E0D7Q35011915-755A1C32-BB2B-4855-93C5-A4D572C4E7B6Q35073407-66C50019-9684-483B-8CAC-AE7D12AD0505Q35696691-D133BCC1-664F-4201-8F10-E7439B74A5F2Q35768659-A2D9C791-9154-45A9-9309-ABB9A57E0E66Q35779019-FDCF3257-CFCB-4003-98C7-BF2316270C83Q36817033-62E3DA68-18BD-4CE1-AE7B-F78F912A60C1Q39407209-FD4C9B19-2AEB-4D13-BA0F-E4C21C8787ABQ39408062-1E797943-ADB1-4D3F-8C80-0170E1FC8AFAQ43817839-5573528E-4CCC-43ED-BA31-F3870DC02D04Q43967356-D0FD396E-F9D7-46C3-87FB-F9C5658CCA9CQ44202492-9D952B45-31A8-43A1-A2AF-4492AF46246CQ45898464-AE70C72A-C785-467C-A3F7-78042DC43FDEQ46197169-C8279D7E-35A9-448B-B259-303BD07F871AQ49010249-0BD7367A-1876-4BBF-A160-4364366AB58BQ52139335-F6759480-FC4C-4E45-B585-0A087B3D1779Q58692280-BDF2AD02-1C98-484A-8EAB-FEF642484ECC
P2860
Current and emerging second-generation triptans in acute migraine therapy: a comparative review.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Current and emerging second-ge ...... therapy: a comparative review.
@ast
Current and emerging second-ge ...... therapy: a comparative review.
@en
type
label
Current and emerging second-ge ...... therapy: a comparative review.
@ast
Current and emerging second-ge ...... therapy: a comparative review.
@en
prefLabel
Current and emerging second-ge ...... therapy: a comparative review.
@ast
Current and emerging second-ge ...... therapy: a comparative review.
@en
P2860
P1476
Current and emerging second-ge ...... therapy: a comparative review.
@en
P2093
P2860
P304
P356
10.1177/00912700022009431
P577
2000-07-01T00:00:00Z